Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CLL1-CD33 cCAR T Cells by ICell Gene Therapeutics for Myeloproliferative Disorders: Likelihood of Approval
CLL1-CD33 cCAR T Cells is under clinical development by ICell Gene Therapeutics and currently in Phase I for Myeloproliferative Disorders....
CLL1-CD33 cCAR T Cells by ICell Gene Therapeutics for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia): Likelihood of Approval
CLL1-CD33 cCAR T Cells is under clinical development by ICell Gene Therapeutics and currently in Phase I for Chronic Myelocytic...
CLL1-CD33 cCAR T Cells by ICell Gene Therapeutics for Myelodysplastic Syndrome: Likelihood of Approval
CLL1-CD33 cCAR T Cells is under clinical development by ICell Gene Therapeutics and currently in Phase I for Myelodysplastic Syndrome....